SScience Read More How the Binding of Two Brain Molecules Creates Memories That Last a LifetimeJuly 7, 2025 The original version of this story appeared in Quanta Magazine. When Todd Sacktor was about to turn 3,…
MMental health Read More ‘Anxious Mondays’ Lead to Stress That Lasts MonthsJuly 7, 2025 Older adults who experience anxiety on Mondays show significantly elevated long-term stress levels—regardless of whether they are still…
GGenetics Read More Neurobiological correlates of schizophrenia-specific and highly pleiotropic genetic risk scores for neuropsychiatric disordersJuly 5, 2025 Harvey AG, Watkins E, Mansell W. Cognitive behavioural processes across psychological disorders: A transdiagnostic approach to research and…
HHealth Read More Cough Medicine Shows Promise in Slowing Parkinson’s DementiaJuly 2, 2025 Summary: A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive…
HHealth Read More Clearing Brain Sugar Stores Could Protect Against DementiaJuly 2, 2025 Summary: New research reveals that sugar metabolism in brain cells may be a crucial defense against Alzheimer’s and…
GGenetics Read More Mimicking Exercise in the Brain Could Slow Cognitive DeclineJune 30, 2025 Summary: While physical activity is known to slow cognitive decline in Alzheimer’s disease, many patients are unable to…
FFitness Read More Exercise Proven to Boost Kids’ Mental HealthJune 29, 2025 Summary: A massive analysis of over 375 trials shows that structured exercise significantly reduces depression and anxiety in…
GGenetics Read More One Gene Rewires Fear Circuits and Fuels AnxietyJune 28, 2025 Summary: Researchers have uncovered how losing the autism-linked gene PTEN in a specific set of inhibitory neurons reshapes…
HHealth Read More Brain Fatigue: How the Mind Decides When to Push or QuitJune 28, 2025 Summary: A new study reveals how the brain responds to mental exhaustion, identifying two key regions—the right insula…
GGenetics Read More AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trialJune 27, 2025 Study design and oversight This ongoing, nonrandomized, open-label, ascending-dose, phase 1b study (ClinicalTrials.gov registration no. NCT03362502) was initiated…